Maywufa CoTPE:1731 86 FCF Margin % is 24.94% as of Dec. 2025, which is 117% above its 10-year median of 11.50. GuruFocus rates TPE:1731 with a GF Score™ of 86/100 and a GF Value™ of NT$26.79 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 963 Drug Manufacturers companies, Maywufa Co ranks better than 76.74% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Maywufa Co's Free Cash Flow for the
three
months ended in Dec. 2025 was NT$103 Mil. Maywufa Co's Revenue for the
three
months ended in Dec. 2025 was NT$415 Mil. Therefore, Maywufa Co's FCF Margin % for the quarter that ended in Dec. 2025 was 24.94%.
The historical rank and industry rank for Maywufa Co's FCF Margin % or its related term are showing as below:
TPE:1731'
s FCF Margin % Range Over the Past 10 Years
Min: -6.63 Med: 11.5 Max: 19.96
Current: 12.84
During the past 13 years, the highest FCF Margin % of Maywufa Co was 19.96%. The lowest was -6.63%. And the median was 11.50%.
TPE:1731's FCF Margin % is ranked better than 76.74% of 963
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs TPE:1731: 12.84
Maywufa Co FCF Margin % Related Terms
Maywufa Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Maywufa Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maywufa Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maywufa Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maywufa Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Maywufa Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maywufa Co (TPE:1731) has a FCF Margin % of 24.94% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maywufa Co and its competitors. This is 117% above median its historical median of 11.50. According to the industry distribution chart, Maywufa Co ranks #224 out of 963 companies in the Drug Manufacturers industry, placing it in the top 23.3%.
Is Maywufa Co's FCF Margin % too high?
Maywufa Co's current FCF Margin % of 24.94% is 117% above median its 10-year median of 11.50. The Drug Manufacturers industry median FCF Margin % is 2.51. Maywufa Co's value of 24.94% is 893.6% above this industry median. Based on the distribution chart, Maywufa Co ranks #224 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Maywufa Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maywufa Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Maywufa Co ranks #224 out of 963 companies for FCF Margin %. This places Maywufa Co in the top 23% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Maywufa Co's value of 24.94% is 893.6% above this benchmark. While the company's 10-year median is 11.50 vs. the industry median of 2.51, Maywufa Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maywufa Co's current FCF Margin % of 24.94% is 893.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maywufa Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maywufa Co's current FCF Margin % is 24.94%, which is 117% above median its own 10-year median of 11.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maywufa Co stock overvalued right now?
Based on GuruFocus' analysis, Maywufa Co (TPE:1731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$26.79, compared to a current price of NT$20.65 — trading 22.9% below its estimated fair value. The current FCF Margin % is 24.94%, which is 117% above median its 10-year median of 11.50 and 893.6% above the Drug Manufacturers industry median of 2.51. Maywufa Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Maywufa Co (TPE:1731), the current FCF Margin % is 24.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maywufa Co (TPE:1731) Overvalued in 2026?
Based on GuruFocus' analysis, Maywufa Co stock appears to be undervalued.
The current stock price of NT$20.65 is trading 22.9% below its estimated GF Value™ of NT$26.79.
GuruFocus considers Maywufa Co to be Modestly Undervalued.
Key valuation signals for TPE:1731:
FCF Margin %: 24.94% (117% above median its 10-year median of 11.50)
GF Value™: NT$26.79 vs. price of NT$20.65 (22.9% below fair value)
Industry Position: 893.6% above the Drug Manufacturers median (#224 of 963)
No single metric tells the full story. See the TPE:1731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maywufa Co Ltd operates as a drug manufacturer. The company is engaged in manufacturing of hair and skin care products. The company has two reportable segments segments: Management Department, Consumer Business Unit, and Pharmaceutical Business Unit. It derives maximum revenue from Pharmaceutical Business Unit.
86GF Score
Get the complete analysis for TPE:1731
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1731 has been successfully added to your 
